Platelet-rich plasma for the treatment of androgenetic alopecia: A patient survey

Background: Although androgenetic alopecia is extremely common, FDA-approved treatments are limited to minoxidil, which may be cumbersome, and finasteride, which has controversial side effects. Platelet-rich plasma (PRP) is a promising new option to fill the gap between medical and surgical options for androgenetic alopecia, with several clinical studies demonstrating PRP's efficacy on a variety of objective measures including hair density. As patient satisfaction is the ultimate goal of treating this aesthetic condition, we sought to determine benefit and satisfaction from a patient perspective.

http://ift.tt/2sol2Pr